Methotrexate ' s First Evidence of Disease Modification in Pre-RA Methotrexate ' s First Evidence of Disease Modification in Pre-RA

Short-term methotrexate used in patients with arthralgia sustainably reduced disease burden and inflammation on MRI in all at-risk groups, according to the first data on pre-RA disease modification.Medscape Medical News
Source: Medscape Orthopaedics Headlines - Category: Orthopaedics Tags: Rheumatology News Source Type: news